About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
In a recent comment letter, PhRMA encouraged CMS to develop key education and outreach tools for beneficiaries on the Medicare Prescription Payment Plan program, to keep beneficiary protections at the forefront of operational calculations and effectuation decision-making, and not to delay decisions related to infrastructure and effectuation details. Our comments were intended to ensure the program meets its goal of improving affordability for Medicare beneficiaries.
PhRMA Comments on Medicare Prescription Payment Plan Draft Part Two Guidance image
Comment
Medicare
PhRMA Comments on Medicare Prescription Payment Plan Draft Part Two Guidance
PhRMA Comments on Medicare Prescription Payment Plan Draft Part Two Guidance image